HEADER HYDROLASE/INHIBITOR 29-DEC-20 7L7N TITLE CRYSTAL STRUCTURE OF HCV NS3/4A D168A PROTEASE IN COMPLEX WITH NR02-59 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NS3 PROTEASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPACIVIRUS C; SOURCE 3 ORGANISM_TAXID: 11103; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS NS3/4A PROTEASE, HEPATITIS C VIRUS, DRUG RESISTANCE, PROTEASE KEYWDS 2 INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX, HYDROLASE, KEYWDS 3 HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.ZEPHYR,C.A.SCHIFFER REVDAT 3 18-OCT-23 7L7N 1 REMARK REVDAT 2 08-SEP-21 7L7N 1 JRNL REVDAT 1 01-SEP-21 7L7N 0 JRNL AUTH D.NAGESWARA RAO,J.ZEPHYR,M.HENES,E.T.CHAN,A.N.MATTHEW, JRNL AUTH 2 A.K.HEDGER,H.L.CONWAY,M.SAEED,A.NEWTON,C.J.PETROPOULOS, JRNL AUTH 3 W.HUANG,N.KURT YILMAZ,C.A.SCHIFFER,A.ALI JRNL TITL DISCOVERY OF QUINOXALINE-BASED P1-P3 MACROCYCLIC NS3/4A JRNL TITL 2 PROTEASE INHIBITORS WITH POTENT ACTIVITY AGAINST JRNL TITL 3 DRUG-RESISTANT HEPATITIS C VIRUS VARIANTS. JRNL REF J.MED.CHEM. V. 64 11972 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34405680 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00554 REMARK 2 REMARK 2 RESOLUTION. 1.59 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.59 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.05 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 26292 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.970 REMARK 3 FREE R VALUE TEST SET COUNT : 1307 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.0500 - 3.3000 1.00 2975 157 0.1691 0.2119 REMARK 3 2 3.3000 - 2.6200 1.00 2849 145 0.1756 0.1902 REMARK 3 3 2.6200 - 2.2900 0.99 2806 150 0.1727 0.1863 REMARK 3 4 2.2900 - 2.0800 0.99 2782 146 0.1889 0.2163 REMARK 3 5 2.0800 - 1.9300 0.99 2783 143 0.1791 0.1936 REMARK 3 6 1.9300 - 1.8200 0.99 2741 153 0.2243 0.2350 REMARK 3 7 1.8200 - 1.7300 1.00 2789 138 0.1992 0.2741 REMARK 3 8 1.7300 - 1.6500 1.00 2757 150 0.2122 0.2067 REMARK 3 9 1.6500 - 1.5900 0.91 2503 125 0.2453 0.2792 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.179 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.301 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.22 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 1554 REMARK 3 ANGLE : 1.168 2129 REMARK 3 CHIRALITY : 0.068 246 REMARK 3 PLANARITY : 0.008 266 REMARK 3 DIHEDRAL : 14.832 237 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7L7N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1000253845. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-SEP-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 703X REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26388 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.590 REMARK 200 RESOLUTION RANGE LOW (A) : 24.056 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.4800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.59 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.65 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5VOJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES BUFFER PH 6.5, 4% (W/V) REMARK 280 AMMONIUM SULFATE, 20-26% PEG 3350 THE CRYSTALS WERE THEN SOAKED REMARK 280 OVERNIGHT IN CRYOGENIC CONDITIONS CONTAINING INHIBITOR (100 MM REMARK 280 MES BUFFER PH 6.5, 4% (W/V) AMMONIUM SULFATE, 20-26% PEG 3350, REMARK 280 15% ETHYLENE GLYCOL, AND 10-20 MM OF INHIBITOR IN DMF), VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.31150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.10450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.36400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 30.10450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.31150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.36400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 962 REMARK 465 GLY A 963 REMARK 465 SER A 964 REMARK 465 SER A 965 REMARK 465 HIS A 966 REMARK 465 HIS A 967 REMARK 465 HIS A 968 REMARK 465 HIS A 969 REMARK 465 HIS A 970 REMARK 465 HIS A 971 REMARK 465 SER A 972 REMARK 465 SER A 973 REMARK 465 GLY A 974 REMARK 465 LEU A 975 REMARK 465 VAL A 976 REMARK 465 PRO A 977 REMARK 465 ARG A 978 REMARK 465 GLY A 979 REMARK 465 SER A 980 REMARK 465 HIS A 981 REMARK 465 ARG A 1180 REMARK 465 SER A 1181 REMARK 465 PRO A 1182 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 987 CG CD CE NZ REMARK 470 ASP A1003 CG OD1 OD2 REMARK 470 GLU A1013 CG CD OE1 OE2 REMARK 470 GLU A1014 CG CD OE1 OE2 REMARK 470 GLN A1021 CG CD OE1 NE2 REMARK 470 LYS A1026 CG CD CE NZ REMARK 470 GLN A1028 CG CD OE1 NE2 REMARK 470 ARG A1092 CG CD NE CZ NH1 NH2 REMARK 470 ARG A1161 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 983 CG - SD - CE ANGL. DEV. = 10.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A1043 -164.40 -163.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1201 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A1097 SG REMARK 620 2 CYS A1099 SG 107.2 REMARK 620 3 CYS A1145 SG 109.4 118.8 REMARK 620 4 HIS A1149 ND1 122.2 100.3 99.4 REMARK 620 N 1 2 3 DBREF1 7L7N A 1004 1180 UNP A0A0B4WYC6_9HEPC DBREF2 7L7N A A0A0B4WYC6 4 180 SEQADV 7L7N MET A 962 UNP A0A0B4WYC INITIATING METHIONINE SEQADV 7L7N GLY A 963 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N SER A 964 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N SER A 965 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N HIS A 966 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N HIS A 967 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N HIS A 968 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N HIS A 969 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N HIS A 970 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N HIS A 971 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N SER A 972 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N SER A 973 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N GLY A 974 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N LEU A 975 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N VAL A 976 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N PRO A 977 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N ARG A 978 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N GLY A 979 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N SER A 980 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N HIS A 981 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N HIS A 982 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N MET A 983 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N ALA A 984 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N SER A 985 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N MET A 986 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N LYS A 987 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N LYS A 988 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N LYS A 989 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N GLY A 990 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N SER A 991 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N VAL A 992 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N VAL A 993 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N ILE A 994 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N VAL A 995 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N GLY A 996 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N ARG A 997 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N ILE A 998 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N ASN A 999 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N LEU A 1000 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N SER A 1001 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N GLY A 1002 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N ASP A 1003 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N GLU A 1013 UNP A0A0B4WYC LEU 13 CONFLICT SEQADV 7L7N GLU A 1014 UNP A0A0B4WYC LEU 14 CONFLICT SEQADV 7L7N GLN A 1017 UNP A0A0B4WYC ILE 17 CONFLICT SEQADV 7L7N GLU A 1018 UNP A0A0B4WYC ILE 18 CONFLICT SEQADV 7L7N GLN A 1021 UNP A0A0B4WYC LEU 21 CONFLICT SEQADV 7L7N SER A 1047 UNP A0A0B4WYC CYS 47 CONFLICT SEQADV 7L7N LEU A 1052 UNP A0A0B4WYC CYS 52 CONFLICT SEQADV 7L7N THR A 1072 UNP A0A0B4WYC ILE 72 CONFLICT SEQADV 7L7N GLN A 1086 UNP A0A0B4WYC PRO 86 CONFLICT SEQADV 7L7N SER A 1159 UNP A0A0B4WYC CYS 159 CONFLICT SEQADV 7L7N ALA A 1168 UNP A0A0B4WYC ASP 168 ENGINEERED MUTATION SEQADV 7L7N SER A 1181 UNP A0A0B4WYC EXPRESSION TAG SEQADV 7L7N PRO A 1182 UNP A0A0B4WYC EXPRESSION TAG SEQRES 1 A 221 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 221 LEU VAL PRO ARG GLY SER HIS HIS MET ALA SER MET LYS SEQRES 3 A 221 LYS LYS GLY SER VAL VAL ILE VAL GLY ARG ILE ASN LEU SEQRES 4 A 221 SER GLY ASP THR ALA TYR ALA GLN GLN THR ARG GLY GLU SEQRES 5 A 221 GLU GLY CYS GLN GLU THR SER GLN THR GLY ARG ASP LYS SEQRES 6 A 221 ASN GLN VAL GLU GLY GLU VAL GLN ILE VAL SER THR ALA SEQRES 7 A 221 THR GLN THR PHE LEU ALA THR SER ILE ASN GLY VAL LEU SEQRES 8 A 221 TRP THR VAL TYR HIS GLY ALA GLY THR ARG THR ILE ALA SEQRES 9 A 221 SER PRO LYS GLY PRO VAL THR GLN MET TYR THR ASN VAL SEQRES 10 A 221 ASP LYS ASP LEU VAL GLY TRP GLN ALA PRO GLN GLY SER SEQRES 11 A 221 ARG SER LEU THR PRO CYS THR CYS GLY SER SER ASP LEU SEQRES 12 A 221 TYR LEU VAL THR ARG HIS ALA ASP VAL ILE PRO VAL ARG SEQRES 13 A 221 ARG ARG GLY ASP SER ARG GLY SER LEU LEU SER PRO ARG SEQRES 14 A 221 PRO ILE SER TYR LEU LYS GLY SER SER GLY GLY PRO LEU SEQRES 15 A 221 LEU CYS PRO ALA GLY HIS ALA VAL GLY ILE PHE ARG ALA SEQRES 16 A 221 ALA VAL SER THR ARG GLY VAL ALA LYS ALA VAL ALA PHE SEQRES 17 A 221 ILE PRO VAL GLU SER LEU GLU THR THR MET ARG SER PRO HET ZN A1201 1 HET XSV A1202 104 HET EDO A1203 10 HET EDO A1204 10 HET SO4 A1205 5 HET SO4 A1206 5 HETNAM ZN ZINC ION HETNAM XSV 1-(TRIFLUOROMETHYL)CYCLOBUTYL [(2R,6S,12Z,13AS,14AR, HETNAM 2 XSV 16AS)-2-{[6-METHOXY-3-(TRIFLUOROMETHYL)QUINOXALIN-2- HETNAM 3 XSV YL]OXY}-14A-{[(1-METHYLCYCLOPROPYL) HETNAM 4 XSV SULFONYL]CARBAMOYL}-5,16-DIOXO-1,2,3,5,6,7,8,9,10,11, HETNAM 5 XSV 13A,14,14A,15,16,16A- HETNAM 6 XSV HEXADECAHYDROCYCLOPROPA[E]PYRROLO[1,2-A][1, HETNAM 7 XSV 4]DIAZACYCLOPENTADECIN-6-YL]CARBAMATE HETNAM EDO 1,2-ETHANEDIOL HETNAM SO4 SULFATE ION HETSYN XSV NR02-59 HETSYN EDO ETHYLENE GLYCOL FORMUL 2 ZN ZN 2+ FORMUL 3 XSV C38 H44 F6 N6 O9 S FORMUL 4 EDO 2(C2 H6 O2) FORMUL 6 SO4 2(O4 S 2-) FORMUL 8 HOH *195(H2 O) HELIX 1 AA1 HIS A 982 MET A 986 5 5 HELIX 2 AA2 GLY A 1012 GLY A 1023 1 12 HELIX 3 AA3 TYR A 1056 GLY A 1060 1 5 HELIX 4 AA4 SER A 1133 LEU A 1135 5 3 HELIX 5 AA5 VAL A 1172 MET A 1179 1 8 SHEET 1 AA1 7 TYR A1006 GLN A1009 0 SHEET 2 AA1 7 VAL A 993 ASN A 999 -1 N ASN A 999 O TYR A1006 SHEET 3 AA1 7 VAL A1033 SER A1037 -1 O ILE A1035 N VAL A 995 SHEET 4 AA1 7 THR A1042 ILE A1048 -1 O ALA A1045 N GLN A1034 SHEET 5 AA1 7 VAL A1051 VAL A1055 -1 O TRP A1053 N THR A1046 SHEET 6 AA1 7 LEU A1082 GLN A1086 -1 O TRP A1085 N LEU A1052 SHEET 7 AA1 7 TYR A1075 ASN A1077 -1 N ASN A1077 O LEU A1082 SHEET 1 AA2 7 ASP A1103 VAL A1107 0 SHEET 2 AA2 7 VAL A1113 ARG A1118 -1 O ILE A1114 N LEU A1106 SHEET 3 AA2 7 ARG A1123 PRO A1131 -1 O SER A1125 N ARG A1117 SHEET 4 AA2 7 VAL A1163 PRO A1171 -1 O ALA A1164 N ARG A1130 SHEET 5 AA2 7 ALA A1150 THR A1160 -1 N ALA A1156 O ALA A1168 SHEET 6 AA2 7 PRO A1142 LEU A1144 -1 N LEU A1143 O VAL A1151 SHEET 7 AA2 7 ASP A1103 VAL A1107 -1 N TYR A1105 O LEU A1144 LINK SG CYS A1097 ZN ZN A1201 1555 1555 2.30 LINK SG CYS A1099 ZN ZN A1201 1555 1555 2.31 LINK SG CYS A1145 ZN ZN A1201 1555 1555 2.31 LINK ND1 HIS A1149 ZN ZN A1201 1555 1555 2.08 CRYST1 54.623 58.728 60.209 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018307 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017028 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016609 0.00000